A 23-year-old woman presents to the emergency department with acute onset of shortness of breath, wheezing, and chest tightness. This is her 4th visit for these symptoms in the last 5 years. She tells you she recently ran out of her normal "controller" medication. Concerned for an asthma exacerbation, you begin therapy with a short-acting beta2-agonist. What is the expected cellular response to your therapy?

Gs protein coupled receptor activates adenylyl cyclase and increases intracellular cAMP

Gq protein coupled receptor activates phospholipase C and increases intracellular calcium

Gq protein coupled receptor activates adenylyl cyclase and increases intracellular cAMP

Gs protein coupled receptor activates phospholipase C and increases intracellular calcium

Gi protein coupled receptor inhibits adenylyl cyclase and decreases cAMP

A 56 year old female comes to the ED complaining of moderate right eye pain, headache, and acute onset of blurry vision, which she describes as colored halos around lights. She was watching a movie at home with her husband about an hour ago when the pain began. On physical exam of her right eye, her pupil is mid-dilated and unresponsive to light. Her right eyeball is firm to pressure. Intraocular pressure (IOP) measured with tonometer is elevated at 36mmHg. Which of the following is the most appropriate emergency treatment?

Epinephrine ophthalmic solution

Anti-cholinergic ophthalmic solution

A 73-year-old man presents to his primary care physician with chest pain. He noticed the pain after walking several blocks, and the pain is relieved by sitting. On exam, he has a BP 155/89 mmHg, HR 79 bpm, and T 98.9 F. The physician refers the patient to a cardiologist and offers prescriptions for carvedilol and nitroglycerin. Which of the following describes the mechanism or effects of each of these medications, respectively?

Increased contractility; Decreased endothelial nitric oxide

Decreased cGMP; Increased venous resistance

Increased heart rate; Decreased arterial resistance

Class II antiarrhythmics (beta blockers) for USMLE Step 3: High-Yield Pharmacology Lessons

Mechanism of Action - The Beta Blockade

Receptor Antagonism: Competitively block β1-adrenergic receptors in cardiac tissue (SA and AV nodes, myocytes), antagonizing catecholamine effects.
Cellular Cascade: This blockade inhibits the Gs-protein pathway, leading to ↓ adenylyl cyclase activity and subsequent ↓ intracellular cAMP.
Electrophysiological Impact:
- SA Node: Decreases the slope of Phase 4 depolarization by reducing the $I_f$ "funny" current, thus ↓ heart rate.
- AV Node: Slows conduction and increases refractoriness, prolonging the PR interval.
- Suppresses EADs/DADs and abnormal automaticity.

⭐ Beta-blockers are uniquely effective in terminating tachyarrhythmias caused by excessive sympathetic stimulation (e.g., post-MI, exercise, thyrotoxicosis).

Pharmacokinetics - In, Around, and Out

Absorption & Distribution
- Lipid solubility dictates CNS penetration.
- High solubility (Propranolol, Metoprolol) → Crosses BBB → CNS side effects.
- Low solubility (Atenolol, Nadolol) → Fewer CNS effects.
Metabolism & Elimination
Half-Lives
- Shortest: Esmolol (IV) ~10 minutes.
- Longest: Nadolol ~24 hours (renal excretion).

⭐ Esmolol is metabolized by RBC esterases, giving it a very short duration of action. This makes it perfect for titrating β-blockade in acute, emergency settings (e.g., aortic dissection, supraventricular tachycardia).

Clinical Use & Side Effects - Friend and Foe

Clinical Use ("Friend"):

Cardiovascular: Post-MI, stable angina, HTN, stable HF (↓ mortality).
Arrhythmias: Rate control in atrial fibrillation/flutter, SVT.
Other: Hyperthyroidism (symptom control), glaucoma, performance anxiety, migraine prophylaxis.

Side Effects ("Foe"):

Cardiovascular: Bradycardia, AV block, hypotension, worsening acute decompensated HF.
Pulmonary: Bronchoconstriction (non-selective agents).
Metabolic: Can mask hypoglycemia symptoms (e.g., tachycardia).
CNS: Fatigue, depression, sexual dysfunction.
⚠️ Warning: Avoid abrupt cessation (rebound tachycardia/HTN).

⭐ In cocaine toxicity, avoid β-blockers due to risk of unopposed α-adrenergic stimulation, leading to extreme hypertension.

The Beta Blocker Lineup - Know Your Players

Mechanism: Block β-adrenergic receptors, ↓ cAMP → ↓ Ca²⁺ currents. Suppress abnormal pacemaker activity & ↓ AV node conduction.
📌 Mnemonic: A to M names (Atenolol, Esmolol, Metoprolol) are β₁-selective; N to Z (Nadolol, Propranolol) are Non-selective.

Agent	Selectivity	Key Features
Metoprolol	β₁ > β₂	Commonly used post-MI.
Propranolol	β₁ = β₂	High lipid solubility, crosses BBB (performance anxiety).
Esmolol	β₁ > β₂	IV only, very short-acting (t½ ≈ 9 min).
Carvedilol	α₁, β₁, β₂	Benefits in heart failure; antioxidant properties.
Labetalol	α₁, β₁, β₂	Safe in pregnancy; used for hypertensive emergencies.

High‑Yield Points - ⚡ Biggest Takeaways

β-blockers decrease cAMP and Ca²⁺ currents, primarily at the SA and AV nodes. They ↓ the slope of phase 4 depolarization, slowing conduction and heart rate. The key EKG finding is an increased PR interval. Primarily used for rate control in atrial fibrillation/flutter and to prevent post-MI ventricular arrhythmias. Major risks include heart block, severe bradycardia, and bronchospasm (non-selective agents).

Continue reading on Oncourse

CONTINUE READING — FREE

or get the app

App Store|Google Play